Skip to main content
Yestar Healthcare Holdings Company Limited logo

Yestar Healthcare Holdings Company Limited — Investor Relations & Filings

Ticker · 2393 LEI · 5493002QYPVH1BR4GF27 HKEX Manufacturing
Open in API
Filings indexed 831 across all filing types
Latest filing 2025-06-27 Board/Management Inform…
Country KY Cayman Islands
Listing HKEX 2393

About Yestar Healthcare Holdings Company Limited

http://www.yestarcorp.com

Yestar Healthcare Holdings Company Limited is a provider of high-margin medical consumables and equipment, primarily serving the healthcare industry in Mainland China. The company's core business encompasses the manufacture, distribution, and sale of medical imaging products and In Vitro Diagnostic (IVD) products. Operating through segments such as Imaging Printing Products and Medical Products and Equipment, key offerings include medical dry films, wet films, and dental films. The Group leverages an extensive domestic sales network and systematic management structure to maintain its position as a leading supplier in its target market.

Recent filings

Filing Released Lang Actions
CHANGE IN COMPOSITION OF BOARD COMMITTEE
Board/Management Information Classification · 1% confidence The document is an announcement by Yestar Healthcare Holdings Company Limited regarding changes in the composition of its board’s nomination committee (an independent non-executive director ceasing committee membership and an executive director’s appointment, along with revisions to the committee’s terms of reference). This clearly falls under announcements of changes in the company’s board or senior management structure, which matches the Board/Management Information category.
2025-06-27 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025
Regulatory Filings Classification · 1% confidence The document is a routine monthly return (Form FF301) filed with the Hong Kong Exchange under Chapter 19B, detailing movements (or lack thereof) in authorised share capital, issued shares, and related confirmations. It is not an earnings release, management presentation, or detailed financial report, nor does it announce any specific capital transaction (no issuance or share split occurred). It is a mandated regulatory filing. Therefore, it falls under the general “Regulatory Filings” category.
2025-06-02 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 30 MAY 2025
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official announcement of poll results at the Annual General Meeting (AGM) with vote counts for each resolution. It reports the votes “for” and “against” resolutions and confirms that all resolutions were duly passed. This corresponds to a Declaration of Voting Results & Voting Rights Announcement.
2025-05-30 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025
Regulatory Filings Classification · 1% confidence The document is a Hong Kong Exchange monthly return (Form FF301) for movements in authorised share capital, issued shares, treasury shares, and related confirmations under Chapter 19B of the Listing Rules. It is a routine regulatory compliance filing rather than a standalone financial report, capital change announcement, share repurchase disclosure, or corporate action notice. It does not fall into any specialized categories (e.g., share issues, buybacks, dividends, AGM materials) and is best classified under general regulatory filings.
2025-05-02 English
PROXY FORM
Proxy Solicitation & Information Statement Classification · 1% confidence The provided text is a form of proxy for use at the company’s upcoming Annual General Meeting, listing resolutions for shareholder voting and instructions for appointing a proxy. This is part of the proxy solicitation materials, not the actual annual report or governance code. It is therefore classified as Proxy Solicitation & Information Statement (PSI).
2025-04-25 English
PROPOSALS FOR GENERAL MANDATES TO ISSUE NEW SHARES AND REPURCHASE SHARES&#x3b; RE-ELECTION OF RETIRING DIRECTORS&#x3b; AND NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a shareholder circular from Yestar Healthcare Holdings, dated 25 April 2025, containing a letter from the Board, proposals for general mandates to issue and repurchase shares, re-election of retiring directors, an explanatory statement, definitions, and the formal notice of the 2025 Annual General Meeting, along with proxy voting instructions. It is clearly a solicitation of shareholder votes and an information statement for the AGM. This aligns precisely with the definition of a Proxy Solicitation & Information Statement (PSI).
2025-04-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.